Alzheon pushes oral Alzheimer’s pipeline forward
Alzheon has initiated Phase 1 trials for **ALZ-507**, a next-generation oral drug candidate aimed at slowing the progression of Alzheimer’s disease. This develo...
landmark
Every story
The whole archive, filed by the part of life it belongs to — and labelled with how strong the evidence behind it actually is.
Showing 2545–2568 of 3,535
Function acquires Getlabs to scale at-home testing
Function's acquisition of **Getlabs** marks a pivotal shift in healthcare delivery, enhancing the accessibility of health data by transforming diagnostics into...
significant
Parkinson’s drug may backfire, study finds
A recent study from Yale School of Medicine, published in *Nature Microbiology*, reveals that **COMT inhibitors**—commonly prescribed to enhance the efficacy of...
significant
Women-only longevity retreat debuts in Bali
Goddess Retreats has launched a **women-only longevity retreat** in Bali, focusing on **functional longevity** through a seven-day health program. This initiati...
Dermatology Devices Market to Reach $25.6 Billion by 2030, Driven by Rising Skin Cancer Incidence and Aesthetic Demand
The **global dermatology devices market** is projected to grow from **$14.4 billion in 2024 to $25.6 billion by 2030**, reflecting a robust **compound annual gr...
ASK4SAM NYC Medical Malpractice Attorneys Silberstein & Miklos, P.C. Expands Focus on Representing Patients Across Manhattan, Brooklyn and Queens
Silberstein & Miklos, P.C., a New York City law firm, is intensifying its efforts to represent patients affected by **medical malpractice** across Manhattan, Br...
Why Fast-Cycling Skin Cells Decrease With Age
Researchers have identified **fibulin-5** as a critical protein in maintaining populations of **fast-cycling skin stem cells**, which decline with age. In a stu...
significant
Subcellular orchestration of microglial aging
**Henze et al.** have advanced our understanding of microglial aging by employing **multiplexed error-robust fluorescence in situ hybridization (MERFISH)** comb...
Positive Phase 2 data show Solengepras benefits in Parkinson’s
Cerevance is set to present **Phase 2 data** for **Solengepras** (CVN424), a novel **non-dopaminergic GPR6 inhibitor**, at the upcoming **American Academy of Ne...
landmark
Longevity market projected to hit $67 billion by 2035
Research by SNS Insider projects the global **longevity market** will grow from **USD 27.61 billion in 2025** to **USD 67.03 billion by 2035**, reflecting a **9...
Mesoblast receives IND clearance to proceed to registrational trial
Mesoblast has received **Investigational New Drug (IND)** clearance from the FDA to advance Ryoncil (remestemcel-L-rknd) into a registrational clinical trial fo...
landmark
American Kidney Fund Announces 2026 Class of Corporate Members Supporting Work to Fight Kidney Disease
The American Kidney Fund (AKF) has announced its **2026 Class of Corporate Members**, which includes prominent biotech and pharmaceutical companies such as **ar...
Eisai to present Lecanemab data at AAN meeting
Eisai Inc. is set to unveil new findings on **Lecanemab** at the upcoming 78th American Academy of Neurology Annual Meeting, scheduled for April 18–22, 2026, in...
significant
Microcap produces anti-aging protein from encapsulated cells
Avaí Bio, in collaboration with Austrianova, is set to unveil findings from their **α-Klotho anti-aging program** at the upcoming Second Annual Klotho Conferenc...
noteworthy
APLMS and Kitalys to Host Healthy Longevity in Hong Kong
The **2026 Asia-Pacific Healthy Longevity International Summit (APAC-LMIS)** will take place in Hong Kong from **October 1-4, 2026**, organized by the **Asia-Pa...
Regeneron rides into radiopharma via $2.1B biobucks pact with Australia’s Telix
Regeneron Pharmaceuticals has announced a strategic partnership with Telix Pharmaceuticals, committing $40 million upfront to advance four solid tumor progr...
significant
Biotech Giants and Investors Gather to Solve the Commercialisation Puzzle This May in Hong Kong
The Asia Summit on Global Health (ASGH), scheduled for May 11-12, 2026, in Hong Kong, aims to tackle critical commercialization challenges facing biotech ex...
New toothpaste stops gum disease without killing good bacteria
Researchers at the **Fraunhofer Institute for Cell Therapy and Immunology** have developed a groundbreaking toothpaste that effectively combats **gum disease**...
Men and women with obesity face very different hidden health risks
New findings from a study presented at the European Congress on Obesity reveal significant sex-based differences in how obesity manifests in men and women. Cond...
significant
PolyPid to Present New Phase 3 SHIELD II Data Demonstrating D-PLEX₁₀₀ Sustained Local Release at ESCMID Global 2026
PolyPid Ltd. has unveiled promising pharmacokinetic data from its Phase 3 SHIELD II trial of D-PLEX₁₀₀, a novel local antibiotic delivery system designed to...
Free Oral Cancer Screenings in Honor of Oral, Head and Neck Cancer Awareness Month
U.S. Oral Surgery Management (USOSM) is launching a nationwide initiative to provide free oral cancer screenings from April 13 to 17, 2026, in collaboration w...
Optum/United Healthcare/United Behavioral Health Expands NeuroStar® TMS Coverage to Include Psychiatric Mental Health Nurse Practitioners
Neuronetics, Inc. has announced a significant policy update from Optum/United Healthcare/United Behavioral Health, which now allows psychiatric mental health...
Nanox Signs Distribution Agreement with Digital X-Ray Imaging to Expand Nanox.ARC Adoption in Arkansas
Nano X Imaging Ltd. has made significant strides in expanding its U.S. commercial presence with a new distribution agreement between its subsidiary, Nanox...
NorthStrive Biosciences Announces U.S. Arrival of EL-32 Working Cell Bank and Initiation of Manufacturing Optimization for Dual Myostatin Assets Targeting Muscle Preservation with GLP-1 Therapies in Collaboration with Modulant Biosciences
NorthStrive Biosciences Inc. has achieved a significant milestone with the transfer of its EL-32 Working Cell Bank (WCB) to a U.S.-based third-party ferment...